Top Markets
Coin of the day
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Classement en actions #27538
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Prix de l'action
$0.0416118
Capitalisation boursière
$32.25M
Changement (1 jour)
-1.67%
Changement (1 an)
-59.58%
Pays
AU
Échange Neurizon Therapeutics Limited (NUZ)

Catégorie

Ratio P/S pour Neurizon Therapeutics Limited (NUZ)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Neurizon Therapeutics Limited, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Neurizon Therapeutics Limited de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
10.17 -
US
11.28 -
US
10.13 -
NL
2.95 -
AU
- -
CH